Fabiana Vitiello
Naples, 80131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Multidisciplinary Decision-Making and Integrated Strategies in Stage III Non-Small Cell Lung Cancer: Exploring Clinical Reasoning in Therapeutic Choices.
Journal: Journal of clinical medicine
Published: March 10, 2026
Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.
Journal: Journal of clinical medicine
Published: November 23, 2025
Correlation of ORR and PFS with OS outcomes in phase III trials of immunotherapy in advanced NSCLC: Systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: June 25, 2025
Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIAL.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 10, 2025
Performance of Control Arms in Trials Leading to FDA Cancer Drug Approvals.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 20, 2025
Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Italian observational study.
Journal: Cancer immunology, immunotherapy : CII
Published: March 09, 2025
Erratum to "Unleashing precision: A review of targeted approaches in pleural mesothelioma" [Crit. Rev. Oncol./Hematol. 203C (2024) 104481].
Journal: Critical reviews in oncology/hematology
Published: September 24, 2024
Case report: Selpercatinib in the treatment of RET fusion-positive advanced lung adenocarcinoma: a challenging clinical case.
Journal: Frontiers in oncology
Published: September 23, 2024
MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Randomized, Prospective SQUINT Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 09, 2024
Last Updated: 09/26/2026